GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · IEX Real-Time Price · USD
9.64
+0.07 (0.73%)
Apr 19, 2024, 4:00 PM EDT - Market closed

GeneDx Holdings Market Cap

GeneDx Holdings has a market cap or net worth of $251.16 million as of April 19, 2024. Its market cap has increased by 8.21% in one year.

Market Cap
251.16M
Enterprise Value
240.28M
1-Year Change
8.21%
Ranking
Category
Stock Price
$9.64

Market Cap Chart

Since September 2, 2020, GeneDx Holdings's market cap has decreased from $448.40M to $251.16M, a decrease of -43.99%. That is a compound annual growth rate of -14.77%.

History

DateMarket Cap% Change
Apr 18, 2024249.30M4.01%
Apr 17, 2024239.70M-4.27%
Apr 16, 2024250.40M-2.72%
Apr 15, 2024257.40M2.71%
Apr 12, 2024250.60M-14.03%
Apr 11, 2024291.50M-3.22%
Apr 10, 2024301.20M6.66%
Apr 9, 2024282.40M3.82%
Apr 8, 2024272.00M4.49%
Apr 5, 2024260.30M10.39%
Apr 4, 2024235.80M-4.22%
Apr 3, 2024246.20M1.28%
Apr 2, 2024243.10M3.31%
Apr 1, 2024235.30M-1.09%
Mar 28, 2024237.90M-3.49%
Mar 27, 2024246.50M8.26%
Mar 26, 2024227.70M3.08%
Mar 25, 2024220.90M-1.52%
Mar 22, 2024224.30M-6.23%
Mar 21, 2024239.20M7.89%
Mar 20, 2024221.70M1.05%
Mar 19, 2024219.40M-12.83%
Mar 18, 2024251.70M-19.56%
Mar 15, 2024312.90M10.49%
Mar 14, 2024283.20M1.58%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Fennec Pharmaceuticals 259.35M
Verastem 258.77M
Ventyx Biosciences 257.75M
Boundless Bio 251.30M
Werewolf Therapeutics 250.87M
AEON Biopharma 249.31M
Xeris Biopharma Holdings 247.20M
AngioDynamics 245.13M
Market Cap Rankings